Le Lézard
Classified in: Health
Subjects: NPT, VET

Taking Care Of Our Veterans


NEW YORK, May 23, 2018 /PRNewswire/ -- This Memorial Day, we memorialize those that died serving our country.  It is easy to forget that we have a real war on our hands right here, as Veterans returning home are committing suicide at the rate of 20 per day.  Now, the trend towards holistic care is showing that there is light for those who fight and return both physically, and emotionally wounded.

Recognizing the need to address "the hidden wounds of war," Tournesol Wellness, Operation Warrior Shield and Anne Akers, Veterans Advocate, have partnered to launch VETWELL, providing a menu of complementary and alternative therapies designed to address the most common conditions faced by our Veterans today.  This includes anxiety and stress as well as fostering a sense of community, often lost in today's society.

With the number of Veterans dealing with anxiety and stress, PTSD and suicide on the increase, the need for alternative therapies has risen.  As a result, a variety of nontraditional techniques --from yoga to meditation to equine therapy --are being employed to help veterans cope with life after service.

At Tournesol Wellness, the VETWELL program provided at no-cost to qualifying Veterans, includes an initial assessment developed by an Integrative MD to identify services needed, evidence based Vibroacoustic Therapy (VAT), transcendental meditation training provided by the David Lynch Foundation, yoga, community acupuncture, and custom workshops designed to address eating, sleeping, moving, breathing and emotional stability as factors in overall emotional well-being and quality of life.

VAT therapy, a service unique to the NY Metro area, has been recognized by the NIH (National Institutes of Health) as a significant factor in reducing pain in Veterans, with reported results of up to a 50% decrease in pain and related symptoms. In addition, Veterans currently enrolled in a pilot program at Tournesol are reporting  positive results  from "my range of motion has improved" to "the experience at Tournesol Wellness has given me a new lease on life.   I feel more calm and confident and as though I can better handle life."

The fiscal sponsor for the VETWELL program is Operation Warrior Shield, a 501c-3, whose mission is to provide comprehensive support for service members, Veterans, first responders and their families.  OWS, under the leadership of its Chairman, CMSgt (retired) Ed Schloeman, was selected as the most innovative not-for-profit of 2017 by the Brooklyn Chamber of Commerce.  Through the combined efforts of Operation Warrior Shield, Tournesol Wellness and Anne Akers, we are able to provide all services to our Veterans at no cost. 

If you would like information on how you can help to support future efforts of this program, including donations and volunteer services, please contact Anne Akers at [email protected].

SOURCE VETWELL


These press releases may also interest you

at 07:13
Throughout July, Kevin Guest, executive chairman at USANA Health Sciences , is emphasizing boosting social connections during "Social Wellness Month." Social wellness?the ability to form meaningful relationships and interact positively with...

at 07:10
The Board of Certification for Emergency Nursing (BCEN), the benchmark for nursing specialty certification across the emergency spectrum, named Maris Panjada as BCEN's new marketing and communications director following the June 28 retirement of...

at 07:05
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen...

at 07:05
Novocure announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company's...

at 07:05
AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...



News published on and distributed by: